Contact us
Home
Publications
Search
Your Account
Help
Resources
Currently 10533 items...
Last updated 04 Sep 2008
Animal / Veterinary
(23)
Biotechnology
(370)
Chemicals
(45)
Company Financials
(2338)
Company Information
(1572)
Top 50 Pharma
(181)
Abbott Laboratories
(6)
Actavis
(3)
Akzo Nobel
(1)
Alcon
(2)
Allergan
(3)
Altana
(0)
Amgen
(6)
Astellas
(6)
AstraZeneca
(8)
Baxter
(2)
Bayer
(7)
Biogen Idec
(3)
Boehringer Ingelheim
(4)
Bristol-Myers Squibb
(4)
Cephalon
(0)
Chungai
(0)
CSL
(0)
Daiichi
(4)
Dainippon Sumitomo
(1)
Eisai
(7)
Eli Lilly
(5)
Genentech
(4)
Genzyme
(2)
Gilead Sciences
(1)
GlaxoSmithKline
(3)
Johnson & Johnson
(9)
King
(1)
Lundbeck
(5)
Merck & Co.
(8)
Merck KGaA
(2)
Mitsubishi
(1)
Novartis
(6)
Novo Nordisk
(4)
Nycomed Pharma
(2)
Otsuka
(1)
Pfizer
(10)
Roche
(6)
Sanofi-Aventis
(7)
Schering AG
(3)
Schering-Plough
(3)
Serono
(4)
Shionogi
(4)
Shire
(5)
Solvay
(3)
Tadeka
(4)
Tanabe Seiyaku
(1)
Teva
(1)
UCB
(2)
Watson
(2)
Wyeth
(4)
Country
(696)
Deals & Alliances
(640)
Dental
(13)
Diagnostics
(115)
Dietary
(86)
Diseases
(427)
Drug Delivery
(77)
Drug Discovery
(89)
Finance / Investment
(18)
General Industry
(118)
Generic Drugs
(350)
Healthcare
(239)
IT & eHealth
(136)
Management / Strategy
(64)
Medical Devices
(863)
Medical Supplies
(13)
OTC drugs
(210)
Pharmacy
(56)
Prescription Drugs
(42)
Production / Manufacturing
(63)
Regulation & Policy
(99)
Research (R&D)
(1077)
Sales & Marketing
(74)
Technology
(113)
Therapeutic
(127)
Treatments
(501)
Advanced Search
Log In
View Basket
Update Your Details
Order History
How to Buy
Formats & Delivery
Account Options
Terms & Conditions
Free Newsletter & Alerts
Industry Events
News
Special Offers »
Home
|
Publications
|
Company Information
|
Top 50 Pharma
|
Astellas
Get free product alerts...
Market research and information on the pharmaceutical company
Astellas Pharma
. (Astellas was formed by through a merger of Fujisawa and Yamanouchi in April 2005).
Stay up-to-date with new products added to this category
Astellas
email this page
print page
Title
Publication Date
Price
Astellas Pharma
Performance, Products, Pipeline and Potential
February 2008
£595
Astellas Pharma Inc.
Pharmavitae Profile
December 2007
£2995
Astellas Pharma: Pipeline, Products, Performance, Potential
November 2007
£595
Astellas Pharma - SWOT Analysis
May 2007
£63
Astellas IMS Company Profile
December 2006
£510
Astellas Pharma Inc Deals Briefing
Partneringdesk
June 2005
£215
Bookmark this Category
Del.icio.us
|
StumbleUpon
|
Reddit
Advertiser Links
back
|
top
© 2008 Piribo Limited
About us
|
Jobs at Piribo
|
Affiliates / Advertising
|
Contact us
|
Custom Research
|
Privacy & security
Deutsch
Español
Français
Italiano
عربي (Arabic)
日本語 (Japanese)
简介 (Chinese)